Relation of Circulating Endothelium-derived Microparticle to Carotid Atherosclerosis

NCT00795067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154

Last updated 2015-03-31

No results posted yet for this study

Summary

The investigators hypothesized that circulating endothelium-derived microparticle (EMP) may be a useful surrogate marker of atherosclerosis and future episode of cerebrovascular events. Peripheral blood is drawn at the time of carotid ultrasound examination. Circulating EMPs are counted using flow-cytometry. The correlation among circulating EMP, ultrasound findings, and atherosclerotic risk factors are determined by multiple stepwise regression analysis. The prevalence of cerebrovascular events is also determined during 3-year follow-up period.

Conditions

Sponsors & Collaborators

  • Kurume University

    lead OTHER

Principal Investigators

  • Tsutomu Imaizumi, MD, PhD · Kurume University

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-11-30
Completion
2013-11-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00795067 on ClinicalTrials.gov